OpenURL Connection Search

Select item for more details and to access through your institution.

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
Published in:
Science Translational Medicine, 2022, v. 14, n. 649, p. 1, doi. 10.1126/scitranslmed.aba4380
By:
- Gigoux, Mathieu;
- Holmström, Morten O.;
- Zappasodi, Roberta;
- Park, Joseph J.;
- Pourpe, Stephane;
- Bozkus, Cansu Cimen;
- Mangarin, Levi M. B.;
- Redmond, David;
- Verma, Svena;
- Schad, Sara;
- George, Mariam M.;
- Venkatesh, Divya;
- Ghosh, Arnab;
- Hoyos, David;
- Molvi, Zaki;
- Kamaz, Baransel;
- Marneth, Anna E.;
- Duke, William;
- Leventhal, Matthew J.;
- Jan, Max
Publication type:
Article
Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.
Published in:
2018
By:
- Deh, Kofi;
- Ponath, Gerald D.;
- Molvi, Zaki;
- Parel, Gian‐Carlo T.;
- Gillen, Kelly M.;
- Zhang, Shun;
- Nguyen, Thanh D.;
- Spincemaille, Pascal;
- Ma, Yinghua;
- Gupta, Ajay;
- Gauthier, Susan A.;
- Pitt, David;
- Wang, Yi;
- Parel, Gian-Carlo T
Publication type:
journal article
Empirical and Rational Design of T Cell Receptor-Based Immunotherapies.
Published in:
Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.585385
By:
- Jones, Heather F.;
- Molvi, Zaki;
- Klatt, Martin G.;
- Dao, Tao;
- Scheinberg, David A.
Publication type:
Article
Challenges and solutions for therapeutic TCR‐based agents.
Published in:
Immunological Reviews, 2023, v. 320, n. 1, p. 58, doi. 10.1111/imr.13233
By:
- Malviya, Manish;
- Aretz, Zita E. H.;
- Molvi, Zaki;
- Lee, Jayop;
- Pierre, Stephanie;
- Wallisch, Patrick;
- Dao, Tao;
- Scheinberg, David A.
Publication type:
Article

Found: 4

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Empirical and Rational Design of T Cell Receptor-Based Immunotherapies.

Challenges and solutions for therapeutic TCR‐based agents.